Cochlear hair cells are vulnerable to a variety of insults like acoustic trauma and ototoxic drugs.
attract leukocytes into the spiral ganglion, and that fractalkine signaling plays a role in macrophage recruitment and in the survival of auditory neurons. Fractalkine (CX 3 CL1), a chemokine that regulates adhesion and migration of leukocytes is expressed by SGNs and signals to leukocytes via its receptor CX 3 CR1. The present study has extended the previous findings to more clinically relevant conditions of sensorineural hearing loss by examining the role of fractalkine signaling after aminoglycoside ototoxicity or acoustic trauma. Both aminoglycoside treatment and acoustic overstimulation led to the loss of hair cells as well as prolonged increase in the numbers of cochlear leukocytes. Lack of CX 3 CR1 did not affect macrophage recruitment after injury, but resulted in increased loss of SGNs and enhanced expression of the inflammatory cytokine interleukin-1b, when compared to mice with intact CX 3 CR1. These data indicate that the dysregulation of macrophage response caused by the absence of CX 3 CR1 may contribute to inflammation-mediated neuronal loss in the deafened ear, suggesting a key role for inflammation in the long-term survival of target-deprived afferent neurons.
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| I N TR ODU C TI ON
Sensorineural hearing loss (SNHL) is caused by damage to the sensory receptors of the cochlea and/or their afferent neurons. Such pathology can occur after exposure to loud sounds, treatment with ototoxic medications, inner ear infections, or as a part of normal aging. It has generally been assumed that the loss of hair cells was the primary cause of SNHL, and that the degeneration of sensory neurons occurred as a secondary consequence of hair cell death (Bohne & Harding, 2000; Johnsson, 1974) . However, results of more recent studies have suggested that the loss of cochlear hair cells does not necessarily lead to the rapid degeneration of spiral ganglion neurons (SGNs) (Kaur et al., 2015; Tong et al., 2015; Zilberstein, Liberman, & Corfas, 2012) . Instead, the loss of SGNs occurs over a period of months to years (Kujawa & Liberman, 2009; Liberman & Kiang, 1978; Oesterle & Campbell, 2009; Schmitz, Johnson, & Santi, 2014; Spoendlin, 1975) . Considered together, these findings underscore the complexity of noise-induced hearing loss (NIHL) and point to our present lack of knowledge regarding the cellular and molecular mechanisms that regulate the survival of cochlear afferents. SGNs are the sole means by which information from the cochlea is conveyed to the brain. As such, long-term survival of SGNs is critical for the preservation of residual hearing and for the success of cochlear prosthetics or any future hair cell restoration strategies in hearing impaired patients.
We recently demonstrated that selective hair cell ablation without any accompanying cochlear pathology in huDTR-Pou4f3 DTR/1 mice (Golub et al., 2012; Tong et al., 2015) is sufficient to recruit leukocytes into the cochlea and results in sustained elevation of macrophage numbers in the spiral ganglion (SG). Our data further suggest that SGNs communicate with macrophages via the ligand fractalkine (CX 3 CL1), that is expressed on expressed by SGNs, interacting with its receptor, CX 3 CR1, that is expressed by cochlear macrophages. We also found that disruption of fractalkine signaling after hair cell death results in decreased macrophage recruitment into the injured cochlea as well as enhanced loss of SGNs (Kaur et al., 2015) . Together, our findings have revealed a critical role for macrophages in auditory pathology and suggest that macrophages have a neuroprotective role via fractalkine signaling in the injured cochlea.
Fractalkine is a chemokine that is expressed as a membrane bound glycoprotein on neurons (Harrison et al., 1998) , peripheral endothelial cells (Bazan et al., 1997; Harrison et al., 2001; Rossi et al., 1998) , and epithelial cells (Lucas et al., 2001) . The fractalkine receptor (CX 3 CR1) is present on microglia and circulating monocytes, dendritic cells, and natural killer cells (Cook et al., 2001; Jung et al., 2000) and also expressed on cochlear macrophages (Hirose, Discolo, Keasler, & Ransohoff, 2005) . Fractalkine occurs in two different forms: as a membrane-bound protein tethered to neuronal membranes by a mucin-like stalk, and as a soluble factor released upon cleavage of its N-terminal chemokine domain (Garton et al., 2001) . The extracellular chemokine domain of fractalkine is proteolytically cleaved from the membrane-bound fraction by the lysosomal cysteine protease, cathepsin S and members of a disintegrin and metalloproteinase (ADAM) family such as ADAM-10
and ADAM-17. The soluble chemokine domain of fractalkine, when cleaved, can act as chemoattractant promoting cellular migration, whereas, membrane-tethered mucin-stalk of fractalkine has been proposed to act as an adhesion molecule for leukocytes during inflammation (Haskell, Cleary, & Charo, 1999; Hermand et al., 2008) . In the central nervous system, fractalkine signaling has been suggested to control microglial neurotoxicity during certain neurodegenerative and neuroinflammatory conditions (Cardona et al., 2006) . In humans, two single-nucleotide polymorphisms (SNPs) produce four allelic receptor variants (Faure et al., 2000; McDermott et al., 2001 , whereas 20% population carry
. Biochemical studies have suggested that the polymorphic variant CX 3 CR1 I249/M280 exhibits defective adhesive properties, therefore leading to deficits in fractalkine signaling (McDermott et al., 2003) . Several studies support a role of CX 3 CR1 in multiple neurodegenerative and neuroinflammatory disorders however, it is still yet to be determined how these changes affect macrophage-neuronal communication and to what extent dysregulated macrophage responses in absence of fractalkine signaling contribute to neuronal pathology in the damaged cochlea.
The present study examined how the lack of CX 3 CR1 influences monocyte/macrophage recruitment and the survival of afferent neurons after both aminoglycoside ototoxicity and acoustic trauma.
CX 3 CR1 wild type, heterozygous, and knockout mice, were given a combination of kanamycin and furosemide or exposed to 120 dB sound pressure level (SPL) noise. Macrophage numbers and SGN density was quantified at acute and prolonged recovery periods after these dB, a threshold of "105 dB" was assigned for that frequency. These threshold values (actual or assigned) were then used to calculate the mean ABR thresholds at each stimulus frequency.
| Histological preparation
Mice were deeply anesthetized with Fatal Plus and perfused with phosphate-buffered 4% paraformaldehyde (PFA) (Electron Microscopy Sciences). Temporal bones were removed and post fixed for 40 min in 4% PFA, rinsed in PBS, and placed in 0.1 M EDTA, to allow decalcification for whole-mount dissections and frozen mid-modiolar sectioning.
| Immunohistochemistry
Decalcified cochleae were processed for immunohistochemical labeling of proteins in both cochlear whole mounts (surface preparations) and frozen mid-modiolar (radial) sections using standard immunofluorescence methods. Briefly, tissue was rinsed with PBS (3X) and incubated at room temperature for 2 hr in blocking solution (5% normal horse serum in 0.2% Triton X-100 in PBS). Cochleae were incubated over- (1:500; Invitrogen or Jackson Immuno Research). The secondary antibody solutions also contained 4,6-Diamidino-2-phenylindole, dihydrochloride (DAPI) (catalog # D9542, Sigma-Aldrich, 1 lg/ml), in order to label cell nuclei. All specimens were coverslipped in glycerol: PBS (9:1) before microscopic imaging.
| Cellular imaging and analyses
Fluorescence imaging was performed using a Zeiss LSM 700 confocal microscope. For both cochlear whole mount or frozen section preparations, Z-series images were obtained using either 103, 203, or 633 objectives. Image processing and quantitative analysis was performed using Volocity 3D image analysis software (v. 6.1.1, PerkinElmer, RRID: SCR_002668).
| Macrophage counts
To assess macrophages per 100 lm of sensory epithelium, GFP-labeled 
| SGN counts
Serial floating radial sections (30 lm) were immunolabeled using standard immunofluorescence methods. Briefly, tissue was rinsed with PBS (3X) and incubated at room temperature for 2 hr in blocking solution (5% normal horse serum in 0.2% Triton X-100 in PBS). Sections were then incubated overnight at room temperature and neurons were labeled with a combination of anti-NF and anti-b-III Tubulin (as described above). Specimens were then rinsed 5X in PBS and incubated for 2 hr in secondary antibody (Alexa Flour 546 anti-mouse IgG; Invitrogen; 1:500). Specimens were coverslipped in glycerol: PBS (9:1) and fluorescent imaging was carried-out using a Zeiss LSM 700 confocal microscope. Z-series images at 1 lm intervals were obtained using a 
| IL-1b immununofluroscence intensity measurements
Fluroscent intensity was measured using Fiji/ImajeJ software (v. 1.47b)
for Mac from National Institute for Health (NIH). Briefly, a region of interest (ROI), that is, SG was drawn and its area, integrated density and mean gray value were measured from 4 to 5 sections per cochlea.
Similary, a region next to SG was selected that had no fluroscence to get background area, integrated density, and mean gray values. Following formula was used to compute corrected total fluorescence (CTF):
CTF 5 Integrated density 2 (Area of selected ROI 3 Mean fluorescence of background readings). CTF was averaged and reported as IL1b fluorescent intensity in SG (arbitrary units).
| Statistical analysis
All the data analysis and statistics were carried out using GraphPad Prism version 7.0a. Data are presented as mean 6 SD. Analyses of variance was applied as appropriate and significance main effects or interactions were followed with the use of Bonferroni's or Tukey's post hoc tests. Results were considered statistically significant when p < .05.
| R E SU LTS
3.1 | Exposure to systemic aminoglycosides or loud noise results profound hair cell death and hearing loss
In order to test whether fractalkine signaling influences macrophage numbers and neuronal survival in biologically-relevant models of acquired SNHL, we employed two previously-established murine models of cochlear injury and hair cell death: aminoglycoside ototoxicity and acoustic trauma (Hirose et al., 2005; Oesterle et al., 2008; Wang, Hirose, & Liberman, 2002) . CX 3 CR1 wild type, heterozygous, and knockout mice were exposed to either a single dose of KF or octaveband (8-16 kHz) noise at 120 dB SPL for 2 hr. Saline treated or unex- but, by 7 days post-noise exposure (DPNE), a nearly-complete loss of
OHCs was observed in the base and middle region of the cochlea (Figure 1d ). There was also profound loss of IHCs in the base and middle region of the cochlea at the same recovery time points post exposure.
By 60 DPNE, there were very few intact hair cells in the organ of Corti.
Furthermore, there was no difference in the degree of hair cell damage among the three genotypes after ototoxic-or noise-injury (data not shown A similar trend was observed in the cochlear epithelium after acoustic injury (Figure 2i-k,p) . However, in the noise-damaged epithelium, some macrophages were seen within the scala media (Figure 2r ) in close proximity to the dying hair cells (Figure 2s ), and were also observed wrapped around degenerating auditory afferent nerve fibers (Figure 2t ).
In the Rosenthal's canal, there was a significant decrease (45%) in the leukocyte numbers at 1 day post noise overexposure, followed by a sustained elevation (approximately twofold) at longer recovery time points (Figure 2l-p) . Complete quantitative data on macrophage numbers after acoustic overexposure are shown in Figure 2p . We also noted an apparent increase in CX 3 CR1 positive immune cell accumulation in the spiral ligament, spiral limbus, borders of scala tympani and scala vestibule and in the modiolus following noise exposure (data not shown). These results resemble our previous finding that leukocyte density increases in the cochlea after sterile injury with density peaking around 2 weeks post injury and remains elevated in the ganglion in close association with SGN cell bodies at longer recovery times.
3.3 | CX 3 CR1 modulates macrophage numbers in the damaged cochlea in an injury dependent manner
In a previous study, we found that the chemokine CX 3 CL1 is expressed by mature SGNs as well as by IHC and certain supporting cells in the sensory epithelium. We also reported that disruption of fractalkine signaling reduces the recruitment of mononuclear phagocytes into the cochlea after selective hair cells ablation (Kaur et al., 2015) . In the present study, we sought to determine whether fractalkine signaling also regulates monocyte/macrophage numbers in the cochlea after ototoxic-or noise-injury. To resolve this issue, macrophage numbers were compared in the cochleae of CX 3 CR1 2/2 mice with those in CX 3 CR1 1/ 2 mice at different recovery times after ototoxic-or acoustic exposure.
We observed a approximately threefold increase in macrophage numbers associated with the cochlear sensory epithelium of CX 3 CR1 1/2 mice at 2 weeks post KF injection (Figure 3c ,e), compared to saline-treated controls (Figure 3a ,e). However, lack of CX 3 CR1 resulted in significantly fewer macrophages (36%) in or near the sensory epithelium after KF injection (Figure 3d ,e). Deletion of CX 3 CR1 did not affect the numbers of resident macrophages in the saline treated animals (Figure 3b ,e), which were similar to those in saline-treated CX 3 CR1 1/2 mice. As described previously (Hirose et al., 2005) , acoustic injury resulted in a two-to threefold increase in macrophage numbers in the sensory epithelium. Notably, deficiency of CX 3 CR1 did not significantly affect those numbers in the noise-damaged epithelium (data not shown). 
| Deficiency of CX 3 CR1 led to enhanced neuronal loss in damaged cochlea
In light of our previous finding that CX 3 CR1 signaling can influence neuronal survival after diphtheria toxin-mediated lesion of cochlear hair cells (Kaur et al., 2015) , we next compared SGN density in the cochleae of CX 3 CR1 2/2 mice and CX 3 CR1 1/2 mice at 2 months after ototoxic- showing GFP-labeled macrophages (green) and afferent nerve fibers (magenta), demonstrate increased numbers of macrophages within sensory epithelium of noise exposed mice (i-k), compared with controls (h). (l-o) Mid-modiolar section from unexposed (control, l) and noise exposed mouse at various recovery times (m-o), showing GFP-expressing macrophages and neurons (magenta). (p) Macrophage density in the sensory epithelium (per 100 lm) and spiral ganglion (per 1,000 lm 2 ) after noise overexposure. (q-t) Representative 3D rendering of cochlear image stacks of noise-damaged cochlea showing macrophages (green) actively phagocytosing hair cell debris (magenta) in the organ of Corti (s) and macrophages wrapped around degenerating afferent nerve fiber (magenta) in the osseous spiral lamina (t). Data expressed as mean 6 SD. n 5 3-7 for each time point for either injury model. Statistical comparisons were made to unexposed or saline treated controls using two-way ANOVA followed by Tukey's multiple comparison post hoc test. *p < .05, **p < .01, ***p < .001, ****p < .0001. Scale 5 30 lm ) resulted in fewer macrophages in the KF-damaged sensory epithelium (d). (e) Number of macrophages in KF-lesioned sensory epithelia. (f, g, k, l) Mid-modiolar sections processed to label macrophages and neurons in the spiral ganglia show normal macrophage density in saline treated or unexposed CX 3 CR1 1/2 (f, k) and CX 3 CR1 2/2 (g, l) mice. (h, i, m, n) Genetic deletion of CX 3 CR1 did not affect macrophage density at 14 days post-KF treatment (i) or 60 days post noise exposure (DPNE) (n) compared to CX 3 CR1 1/2 mice (h, m). (j, o) Macrophage density in the spiral ganglion. Data expressed as mean 6 SD. n 5 3-9 for each genotype and treatment group for either injury models. Statistical significance was computed using two-way ANOVA followed by Tukey's multiple comparison test. *p < .05, **p < .01, ***p < .001. n.s. 5 not significant. Scale 5 30 lm (a-d), 35 lm (f-i), 63 lm (k-n) reduction), when compared to CX 3 CR1 1/2 littermate controls ( Figure   4e ). With acoustic trauma, significant neuronal loss (29% reduction) in CX 3 CR1 2/2 mice was mainly observed in the apical and middle region of the cochleae (Figure 4j) . We also noted an (Figure 4c ,e,h,j).
| Enhanced production of IL-1b in CX 3 CR1 deficient injured cochlea
Our data show that disruption of fractalkine signaling leads to reduced SGN survival after cochlear injury. How might macrophages and/or fractalkine signaling affect the survival of cochlear afferents? Studies in the central nervous system have suggested that fractalkine signaling can regulate the activation status of microglia (brain resident macrophages), thereby influencing the production of several cytokines (Cardona et al., 2006 (Cardona et al., , 2015 . Such neuronal pathology has been attributed to enhanced microglial expression of cytotoxic cytokines such as IL-1b.
In order to determine whether a similar mechanism occurs in the cochlea after deletion of CX 3 CR1, we assessed macrophage production of IL-1b after cochlear damage. Cochlear mid-modiolar frozen sections from saline and KF-treated mice were immunolabeled for IL-1b. Saline treated (CX 3 CR1 1/2 and CX 3 CR1
2/2 ) tissue staining revealed low levels of IL-1b in the spiral ganglia of the cochlea (Figure 5c ). However, following KF injury, a significant upregulation of IL-1b was detected in CX 3 CR1 2/2 mice (Figure 5b,c) . In contrast, increased IL-1b was not observed in comparably injured CX 3 CR1 1/2 mice (Figure 5a,c) . The source of IL-1b in the SG is not clear, but double immunofluorescence labeling in the spiral ligament of CX 3 CR1 2/2 mice indicate that macrophages may contribute to IL-1b production (Figure 5d ). However, other   FIG URE 4 Absence of CX 3 CR1 is associated with reduced neuronal survival after cochlear injury. Cochlear mid-modiolar sections from the middle and basal cochlear turns immunolabeled for neurofilament (neurons, magenta) revealed significant loss of spiral ganglion cell bodies in the CX 3 CR1 2/2 mice (d, i) compared with CX 3 CR1 1/2 mice (c, h), at 60 days post KF injection or noise exposure, respectively. There was no evident loss of spiral ganglion neurons (SGNs) in saline treated or unexposed CX 3 CR1 1/2 (a, f) and CX 3 CR1 2/2 (b, g) mice. (e, j) Quantitative data on SGN density (per 1,000 lm 2 ) from all cochlear turns. Data expressed as mean 6 SD. n 5 3-9 for each genotype and treatment group for either injury models. Statistical significance was computed using two-way ANOVA followed by Tukey's multiple comparison post hoc tests. *p < .05, ***p < .001, ****p < .0001. Scale 5 30 lm cells types such as glia and neurons might also produce IL-1b (Cardona et al., 2015) . It should also be noted that IL-1b upregulation was not observed in the noise-damaged cochlea of CX 3 CR1 2/2 mice (data not shown) at any post recovery time point . The lack of IL-1b in the noise exposed CX 3 CR1 2/2 mice does rule out the possibility that IL-1b may have been upregulated earlier than 24 hr post noise exposure or that other cytokines could be responsible for SGN loss.
| D I SCUSSION
Our previous study demonstrated that genetic deletion of CX 3 CR1 in mice led to decreased macrophage numbers and enhanced neuronal loss in the cochlea after selective hair cell ablation (Kaur et al., 2015) .
We have now extended these results to more biologically relevant scenarios, and examined whether CX 3 CR1 deletion also resulted in enhanced SGN loss after KF ototoxicity or acoustic trauma. Our data show enhanced neuronal loss in both ototoxic-and noise-damaged cochleae that lack fractalkine signaling. These results point to a key role of cochlear inflammation in regulating the long-term survival of target-deprived afferent neurons.
Although the inner ear was previously thought to be immuneprivileged, cochlear injury has been shown to cause recruitment of immune cells to lesion sites (Fredelius et al., 1990) . These immune cells have subsequently been identified as monocytes and macrophages based on the expression of CD45, F4/80, Iba-1, CD11b, and CX 3 CR1 (Hirose et al., 2005; Ladrech, Wang, Simonneau, Puel, & Lenoir, 2007; Sato et al., 2010; Sautter, Shick, Ransohoff, Charo, & Hirose, 2006; Tornabene, Sato, Pham, Billings, & Keithley, 2006; Yang, Vethanayagam, Dong, Cai, & Hu, 2015) . It has been further proposed that circulating monocytes and macrophages migrate into the cochlea through the vasculature of the lateral wall, modiolus and ganglion (Hirose et al., 2005) . mice in the spiral ligament after 2 months post KF treatment, whereas no immunoreactivity was detected in the macrophages of injured CX 3 CR1 1/2 mice. Data expressed as mean 6 SD. n 5 3-9, ****p < .0001. Scale 5 63 lm (a, b), 33lm (d) in the scala media engulfing hair cell debris and surrounding the tectorial membrane immediately after noise overexposure. This may be attributed to the breach in the reticular lamina at 120 dB noise level (Wang et al., 2002) . Such breach can cause intermixing of cochlear fluids thereby diluting the high potassium ion concentration in the endolymph that has been proposed to be incompatible with macrophage survival (Sato et al., 2010) . It is also possible that macrophages in the scala media helps promote repair of the ruptured reticular lamina by clearing debris in the organ of Corti and/or by secreting unknown factors necessary for repair. In this light, it is notable that the endocochlear potential never recovers in young C57BL/6J animals exposed to 120 dB SPL noise level (Ohlemiller, Kaur, Withnell, & Warchol, unpublished observations) . (Auffray et al., 2007; Davalos et al., 2005; Elliott et al., 2009; Ravichandran, 2010; Truman et al., 2008) . We have previously demonstrated fractalkine expression by the IHC and SGNs (Kaur et al., 2015) . However, we found no difference in the macrophages numbers in the SG between CX 3 CR1 heterozygous, and knockout mice after 24 hr of noise exposure (data not shown) suggesting that fractalkine is unlikely to be the signal that attracts resident macrophages from the SG toward the epithelium. Macrophages express purinergic (P2RX and P2RY) receptors (Elliott et al., 2009 ) and ATP is released from the cochlear sensory epithelium after hair cell injury (Lahne & Gale, 2008) . Future studies will focus on determining if nucleotide/P2R signaling is the "find-me" signal.
The SG contained higher numbers of CX 3 CR1-GFP positive monocytes/macrophages at 1 week after noise exposure. Also, in contrast to the cochlear epithelium, monocyte/macrophage numbers in the ganglion remained elevated at longer recovery periods. It is possible that the lack of spontaneous activity and/or sensory input following hair cell loss causes macrophage recruitment in the ganglion, but the signal that triggers this response is unclear. Also, the precise nature/phenotype of recruited immune cells in the ganglion of damaged cochlea remains to be characterized. Based on studies of injured spinal cord (Kigerl et al., 2009; Shechter et al., 2009) , it is possible that the resident macrophages are phagocytic and that the recruited macrophages are resolving/protective in nature. Future studies will be necessary to understand the heterogeneity of immune cells and their differential functions in damaged cochlea.
Our previous study suggested fractalkine signaling as a chemotactic factor and reported an overall reduction in macrophage numbers in the CX 3 CR1-deficient mice after selective hair cell ablation (Kaur et al., 2015) . However, this was not the case with KF-or noise-induced hearing loss. Consistent with Sato et al. (2010) , there was an increased accumulation or activation of leukocytes in the lateral wall of CX 3 CR1 2/2 mice after KF ototoxicity (data not shown). This response resembles the increased microglial activation in CX 3 CR1-deficient mice that has been reported in multiple mouse models of neurodegenerative and neuroinflammatory disorders such as Parkinson's disease, Alzheimer disease, amyotrophic lateral sclerosis, or diabetic retinopathy (Cardona et al., 2006 (Cardona et al., , 2015 . Also, lack of fractalkine signaling did not significantly affect macrophage numbers in the ganglion of KF-or noise-damaged cochlea. These findings suggest that regulation of macrophage numbers by fractalkine signaling in injured cochlea is complex and that fractalkine-chemotactic properties cannot completely account for macrophage recruitment that occurs following different forms of cochlear injury. It has been proposed that CX 3 CR1 is an important signal that limits the migration of monocytes/macrophages from the circulation into the damaged tissue, where the blood-brain barrier is intact (Cardona et al., 2006) . When the blood-brain barrier is disrupted, the roles of CX 3 CL1/CX 3 CR1 may be quite different. The damage induced by KF or loud noise exposure is often nonselective and alters the cochlear blood-labyrinth barrier (Hirose, Li, Ohlemiller, & Ransohoff, 2014; Schmitz et al., 2014; Tornabene et al., 2006; Wang et al., 2002) , and we speculate that it is the integrity of cochlear vasculature that might influence the chemotactic properties of fractalkine in different cochlear injury models. Because fractalkine is readily degraded by metalloproteases (Garton et al., 2001; Wong et al., 2014) , it is possible that fractalkine may have a shorter half-life and is unlikely to serve as longrange "find-me" signal to leukocytes in circulation. Instead, fractalkine may primarily attract tissue resident macrophages.
Despite the lack of significant change in macrophage density, our data extend the findings of neuronal reduction in the damaged cochlea, and provide novel insights into the inflammatory reaction in the context of hearing loss using ototoxic or acoustic trauma model and dysregulated immune response in absence of CX 3 CR1 signaling. Previous studies of the cochlea have demonstrated extensive hair cell loss and hearing loss in CX 3 CR1-knockout mice (compared to CX 3 CR1-expressing animals) after kanamycin exposure (Sato et al., 2010) . Similarly, studies in the CNS have reported enhanced neurotoxicity and inflammation in mice lacking CX 3 CR1 in models of low-endotoxemia, Parkinson's disease, Amyotrophic lateral sclerosis, and Diabetic retinopathy (Cardona et al., 2006 (Cardona et al., , 2015 . Such pathology has been attributed to enhanced microglial expression of inflammatory cytokines like IL-1b, TNF-a, and IL-6. In a search for differentially regulated inflammatory cytokines in the damaged cochlea, we observed that IL-1b was predominantly expressed in the SG, likely by macrophages, of damaged CX 3 CR1 2/2 mice. Several studies have reported IL-1b expression in the damaged cochlea (Fujioka et al., 2006; Tan, Thorne, & Vlajkovic, 2016; Tornabene et al., 2006) but absence of CX 3 CR1 exaggerates this response and our data suggests a correlation between IL-1b production and neuronal loss in CX 3 CR1 knockout mice. IL-1b, the first discovered interleukin, may play dual roles during inflammatory disorders. In most conditions, elevated concentration of IL-1 is toxic to neurons and has been associated with multiple neurodegenerative disorders. However, neuroprotective properties of IL-1b has also been suggested in deafened guinea pigs (Komeda, Roessler, & Raphael, 1999) . Further studies will be necessary to demonstrate the neurotoxic properties of IL-1b in damaged cochlea and the effects of IL-1b blockade on neuronal survival. Finally, the lack of IL-1b upregulation in noise-damaged cochleae of CX 3 CR1 knockout mice further suggests that there may be other cytotoxic cytokines or factors that can cause SGN loss.
Human populations possess two SNPs in CX 3 CR1: V249I and T280M (Faure et al., 2000) . Most individuals carry CX 3 CR1
V249/T280
, whereas 20-30% carry CX 3 CR1 I249/M280
. Biochemical studies have suggested that the polymorphic variant CX 3 CR1 I249/M280 exhibits defective adhesive properties, therefore leading to deficits in fractalkine signaling (Faure et al., 2000; McDermott et al., 2003) . These var- 
